ArticleJournal of clinical microbiology2006
Measles virus-specific antibody levels in individuals in Argentina who received a one-dose vaccine.
Article in Journal of clinical microbiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 22 citations in OpenAlex.
- Protective antibody response following two doses of measles vaccination and factors for non-response among children from tribal Odisha, India.The Indian journal of medical research · 2026Article
- COVID-19 pandemic and waning immunity disrupted measles population immunity and strategies to close immunity gaps.Nature communications · 2025Article
- Dynamics of measles immunity from birth and following vaccination.Nature microbiology · 2024Article
- Long-term measles antibody profiles following different vaccine schedules in China, a longitudinal study.Nature communications · 2023Article
- Measles Outbreak in a Rural Population in Bahar District, Hamadan Province, West of Iran in 2018.Journal of research in health sciences · 2020Article
- Synthesis of Evidence to Characterize National Measles and Rubella Exposure and Immunization Histories.Risk analysis : an official publication of the Society for Risk Analysis · 2016Article
- Measles susceptibility in young Thai men suggests need for young adult measles vaccination: a cross sectional study.BMC public health · 2016Article
- Antigen vehiculization particles based on the Z protein of Junin virus.BMC biotechnology · 2012Article
- Low titers of measles antibody in mothers whose infants suffered from measles before eligible age for measles vaccination.Virology journal · 2010Article
- Expression and purification of Z protein from Junín virus.Journal of biomedicine & biotechnology · 2010Article
- Prevalence of Maternal Measles Antibody and Its Associated Factors among Infants in Coastal Karnataka, India.Indian journal of community medicine : official publication of Indian Association of Preventive & Social MedicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In spite of active measles virus (MV) vaccination strategies, reemergence continues to occur, impairing global eradication programs. The immune status against measles was evaluated in 350 vaccinated healthy Argentine children and teenagers who received a single dose of the MV Schwarz strain Lirugen vaccine (Aventis Pasteur). Sera were assessed for immunoglobulin G (IgG) antibodies by a commercial enzyme immunoassay (EIA) (Enzygnost; Behring), an in-house EIA, and neutralization EIA. Results obtained with these methods showed a marked decline in IgG level with increasing age. At 1 to 4 years of age, 84% of children had IgG antibodies above 200 mIU/ml, conventionally accepted as protective levels, whereas only 32% of older children and teenagers had antibody levels exceeding 200 mIU/ml. Moreover, the MV IgG content in the teenage group was significantly lower than the IgG antibody level of the group of younger children (P < 0.0001). In contrast, screening for IgG antibody levels to inactivated tetanus vaccine showed that, on average, 80% of this population was fully protected and that this high level of protection remained through the teenage years. This study suggests that within this population a considerable proportion of individuals had low measles antibody levels that may be insufficient to protect against reinfections or clinical disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.